The study focuses on developing acacia gum-stabilized gold nanoparticles loaded with doxorubicin (DOX) for targeted breast cancer treatment, aiming for better therapeutic effects with fewer side effects.* !
-
Characterization techniques like HR-TEM and FT-IR confirmed the nanoparticle's structure, while in vitro tests showed higher drug release at acidic pH typical of tumors, leading to improved efficacy.* !
-
The DOX-AGNPs were more cytotoxic to breast cancer cells than free DOX, although stability tests indicate some limitations under storage conditions, highlighting their potential in cancer therapy.* !